Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139498 · ClinicalTrials.gov registry record · NA
Conservative Management for PAS Pilot
A NA study of Placenta Accreta, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05139498: Recruiting NA study of Placenta Accreta, sponsored by University of Utah.
NCT05139498 is a NA study of Placenta Accreta that is actively recruiting participants, run by University of Utah. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05139498, a NA study of Placenta Accreta, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Conservative in situ management is a promising alternative treatment to hysterectomy for patients with placenta accreta spectrum and may be safer and preferable for some patients. This study will assess feasibility of a future randomized clinical trial comparing these treatments and provide novel data to inform shared decision-making and cost-effective care for patients with this deadly pregnancy disorder.
Primary Outcome
Number of patients completing the surgical treatment to which they are allocated (hysterectomy or conservative management) on the day of delivery.
Conditions Studied
Interventions
- PROCEDURE Conservative management for placenta accreta spectrum (PAS)
- PROCEDURE Cesarean hysterectomy for placenta accreta spectrum (PAS)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-05-26 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05139498 shows while recruiting
NCT05139498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Placenta Accreta appearing as the primary indexed condition, and to 2 interventions - of which Conservative management for placenta accreta spectrum (PAS) is the first listed.
NCT05139498 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05139498 about?
NCT05139498 is a clinical study titled "Conservative Management for PAS Pilot". Conservative in situ management is a promising alternative treatment to hysterectomy for patients with placenta accreta spectrum and may be safer and preferable for some patients. This study will assess feasibility of a future randomized clinical trial comparing these treatments and provide novel da...
What is the current status of trial NCT05139498?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-05-26. Estimated completion is 2026-06-30.
What conditions does trial NCT05139498 study?
This clinical trial studies the following conditions: Placenta Accreta.
What interventions are being tested in trial NCT05139498?
The interventions under investigation include: Conservative management for placenta accreta spectrum (PAS) (PROCEDURE), Cesarean hysterectomy for placenta accreta spectrum (PAS) (PROCEDURE).
Who is sponsoring clinical trial NCT05139498?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05139498 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Placenta Accreta
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05139498's enrollment target sits among peer trials
32 1579th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI